| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787580 | Journal of Thoracic Oncology | 2018 | 58 Pages |
Abstract
Adoption of the modified RECIST 1.1 guidelines for mesothelioma is recommended to harmonize the application of tumor measurement and response assessment across the next generation of clinical trials in this disease.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Samuel G. PhD, Anna K. MBBS, FRACP, PhD,